Thermo Fisher Scientific Inc. closed $81.56 short of its 52-week high ($627.88), which the company achieved on September 10th ...

Contract drug manufacturers witnessed reduced spending from biotech clients last year, but recent interest cuts could improve ...

Thermo Fisher Scientific is the world leader in serving science. We provide cutting-edge technologies, innovative solutions, and comprehensive services to a diverse range of industries, including ...

In this article, we are going to take a look at where Thermo Fisher Scientific Inc. (NYSE:TMO) stands against other best ...

Thermo Fisher Scientific (NYSE:TMO) traded lower in the premarket on Wednesday as the Waltham, Massachusetts-based healthcare giant reaffirmed its 2024 revenue outlook after falling short of ...

Thermo Fisher has outperformed the market with a 420%+ return over the past decade, but its current valuation is high. The company’s recent results show mixed performance, with a slight revenue ...

A transformative shift in energy research is taking shape, driven by a dynamic collaboration between the University of ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Healthcare Services (HCSG – Research ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.16% of ...

(Reuters) -One of the largest contract drug manufacturing plants in the U.S. owned by Thermo Fisher Scientific over the past 10 years has repeatedly breached rules meant to ensure drugs are free of ...

In this article, we are going to take a look at where Thermo Fisher Scientific Inc. (NYSE ... and Tenet Healthcare Corporation (NYSE:THC) are among the biggest in the world, benefiting from ...